{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:24:48Z","timestamp":1793471088398,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007941","name":"Addis Ababa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007941","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia.","award":["CHS\/RTTD\/131\/2018"],"award-info":[{"award-number":["CHS\/RTTD\/131\/2018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s43441-025-00756-4","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:46:12Z","timestamp":1738928772000},"page":"379-396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessment of Local Pharmaceutical Manufacturing Sector in a Low-income Country: A Descriptive Study"],"prefix":"10.1007","volume":"59","author":[{"given":"Tesfa","family":"Marew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anteneh","family":"Belete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances J.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7619-2270","authenticated-orcid":false,"given":"Tsige","family":"Gebre-Mariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"756_CR1","unstructured":"Mikulic M. Revenue of the worldwide pharmaceutical market from 2001 to 2023.: Statista; 2024 [Available from: https:\/\/www.statista.com\/statistics\/263102\/pharmaceutical-market-worldwide-revenue-since-2001\/]"},{"issue":"4","key":"756_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/17441692.2017.1396354","volume":"13","author":"EM da Fonseca","year":"2018","unstructured":"da Fonseca EM. How can a policy foster local pharmaceutical production and still protect public health? Lessons from the health\u2013industry complex in Brazil. Glob Public Health. 2018;13(4):489\u2013502.","journal-title":"Glob Public Health"},{"issue":"2","key":"756_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.healthpol.2008.01.003","volume":"87","author":"S Morgan","year":"2008","unstructured":"Morgan S, McMahon M, Greyson D. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia. Health Policy. 2008;87(2):133\u201345.","journal-title":"Health Policy"},{"key":"756_CR4","unstructured":"Kim IS, Milner VH. Multinational corporations and their influence through lobbying on Foreign Policy. Multinational corporations in a changing Global Economy. 2019;9(4):497\u2013536."},{"issue":"1","key":"756_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2190\/HS.43.1.f","volume":"43","author":"M Flynn","year":"2013","unstructured":"Flynn M. Brazilian pharmaceutical diplomacy: social democratic principles versus soft power interests. Int J Health Serv. 2013;43(1):67\u201389.","journal-title":"Int J Health Serv"},{"issue":"2","key":"756_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2307\/1562501","volume":"99","author":"FM Abbott","year":"2005","unstructured":"Abbott FM. The WTO medicines decision: world pharmaceutical trade and the protection of public health. Am J Int Law. 2005;99(2):317\u201358.","journal-title":"Am J Int Law"},{"issue":"2","key":"756_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1748-720X.2009.00369.x","volume":"37","author":"JH Reichman","year":"2009","unstructured":"Reichman JH. Compulsory licensing of Patented Pharmaceutical inventions: evaluating the options. J Law Med Ethics. 2009;37(2):247\u201363.","journal-title":"J Law Med Ethics"},{"key":"756_CR8","doi-asserted-by":"crossref","unstructured":"Ogbodum MU, Shomuyiwa DO, Lucero-Prisno III, DE. African Medicines Agency: how it will change the landscape of medicines in Africa. Public Health Challenges. 2023;2(2):e96.","DOI":"10.1002\/puh2.96"},{"issue":"1","key":"756_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40545-020-00281-9","volume":"14","author":"BM Ncube","year":"2021","unstructured":"Ncube BM, Dube A, Ward K. Establishment of the African Medicines Agency: progress, challenges and regulatory readiness. J Pharm Policy Pract. 2021;14(1):29.","journal-title":"J Pharm Policy Pract"},{"key":"756_CR10","volume-title":"Supporting Pharmaceutical production in Africa","author":"UNIDO","year":"2015","unstructured":"UNIDO. Supporting Pharmaceutical production in Africa. Austria: United Nations Industrial Development Organization (UNIDO); 2015."},{"issue":"1","key":"756_CR11","first-page":"1","volume":"43","author":"W Fisher","year":"2022","unstructured":"Fisher W, Okediji RL, Padmashree GS. Fostering production of Pharmaceutical products in developing countries. Mich J Int\u2019l L. 2022;43(1):1\u201361.","journal-title":"Mich J Int\u2019l L"},{"key":"756_CR12","unstructured":"Ouma-Mugabe J. Existential Priorities for the African Continental Free Trade Area. J, MFaA-M, editor: United Nations Economic Commission for Africa; 2022."},{"key":"756_CR13","doi-asserted-by":"crossref","unstructured":"Gebre-Mariam T, Tahir K, Gebre-Amanuel S. Bringing industrial and health policies closer: reviving pharmaceutical production in Ethiopia. Making medicines in Africa: the political economy of industrializing for local health. 2016:65\u201384.","DOI":"10.1007\/978-1-137-54647-0_5"},{"issue":"1","key":"756_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12913-023-09535-z","volume":"23","author":"Z Mekonnen","year":"2023","unstructured":"Mekonnen Z, Melaku T, Tucho GT, et al. The knock-on effects of COVID-19 pandemic on the supply and availability of generic medicines in Ethiopia: mixed methods study. BMC Health Serv Res. 2023;23(1):513.","journal-title":"BMC Health Serv Res"},{"key":"756_CR15","volume-title":"Context assessment and profile database development of the local pharmaceuticals, medical supplies and medical devices manufacturers in Ethiopia","author":"PMED","year":"2020","unstructured":"PMED. Context assessment and profile database development of the local pharmaceuticals, medical supplies and medical devices manufacturers in Ethiopia. Addis Ababa: Pharmacy and Medical Equipment Directorate (PMED), Ministry of Health, Government of Ethioipia.; 2020."},{"issue":"5","key":"756_CR16","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.4314\/ejhs.v32i5.18","volume":"32","author":"T Marew","year":"2022","unstructured":"Marew T, Richmond FJ, Belete A, et al. Trends and challenges in access to essential medicines in Ethiopia and the contributions of local pharmaceutical production. Ethiop J Health Sci. 2022;32(5):1027\u201342.","journal-title":"Ethiop J Health Sci"},{"key":"756_CR17","doi-asserted-by":"crossref","unstructured":"Gebremedhin Beedemariam GB, Efrem Nigussu EN, Gutu Tefera GT et al. Assessment of GMP compliance in water treatment systems of pharmaceutical industries in Ethiopia. 2015.","DOI":"10.22270\/jddt.v5i2.1058"},{"key":"756_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-018-3410-5","volume":"18","author":"C Alemayehu","year":"2018","unstructured":"Alemayehu C, Mitchell G, Nikles J, et al. Views and perceptions about locally manufactured medicines in Ethiopia: a qualitative study of physicians, patients and regulatory authorities. BMC Health Serv Res. 2018;18:1\u201310.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"756_CR19","doi-asserted-by":"publisher","first-page":"e0281665","DOI":"10.1371\/journal.pone.0281665","volume":"18","author":"MN Selam","year":"2023","unstructured":"Selam MN, Mengstu AT, Fentie AM, et al. Health professionals\u2019 perceptions on local production and bioequivalence study of generic medicines: a cross-sectional survey of physicians and pharmacy professionals in Addis Ababa, Ethiopia. PLoS ONE. 2023;18(3):e0281665.","journal-title":"PLoS ONE"},{"key":"756_CR20","volume-title":"Sampling techniques","author":"WG Cochran","year":"1963","unstructured":"Cochran WG. Sampling techniques. New York: John Wiley and Sons, Inc.; 1963."},{"key":"756_CR21","first-page":"9","volume":"1","author":"N Lin","year":"2006","unstructured":"Lin N, Winn TB, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Archives Orofac Sci. 2006;1:9\u201314.","journal-title":"Archives Orofac Sci"},{"issue":"1","key":"756_CR22","first-page":"25","volume":"3","author":"TS Nanjundeswaraswamy","year":"2021","unstructured":"Nanjundeswaraswamy TS, Divakar S. Determination of sample size and sampling methods in applied research. Proc Eng Sci. 2021;3(1):25\u201332.","journal-title":"Proc Eng Sci"},{"key":"756_CR23","volume-title":"Research methods for Business Students","author":"S Mark","year":"2009","unstructured":"Mark S, Philip L, Adrian T. Research methods for Business Students. New Jersey: Prentice Hall; 2009."},{"issue":"5","key":"756_CR24","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1108\/IJOPM-01-2013-0009","volume":"35","author":"Y Cheng","year":"2015","unstructured":"Cheng Y, Johansen J, Hu H. Exploring the interaction between R&D and production in their globalisation. Int J Oper Prod Manage. 2015;35(5):782\u2013816.","journal-title":"Int J Oper Prod Manage"},{"issue":"5","key":"756_CR25","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.phrp.2015.10.013","volume":"6","author":"M Lee","year":"2015","unstructured":"Lee M, Choi M. The determinants of research and development investment in the pharmaceutical industry: focus on financial structures. Osong Public Health Res Perspect. 2015;6(5):302\u20139.","journal-title":"Osong Public Health Res Perspect"},{"key":"756_CR26","volume-title":"Pharmaceutical partnerships for increased Access to Quality essential Medicines in the East Africa Region: final report","author":"S Vugigi","year":"2020","unstructured":"Vugigi S, Wanyanga W, Keter KF. Pharmaceutical partnerships for increased Access to Quality essential Medicines in the East Africa Region: final report. Nairobi: The Scinnovent Centre; 2020."},{"issue":"1\u20133","key":"756_CR27","first-page":"3","volume":"20","author":"SK Vugigi","year":"2017","unstructured":"Vugigi SK, Thoithi GN, Ogaji JI, et al. Production capacity of the pharmaceutical manufacturing industry in Kenya. East Cent Afr J Pharm Sci. 2017;20(1\u20133):3\u201312.","journal-title":"East Cent Afr J Pharm Sci"},{"issue":"15","key":"756_CR28","doi-asserted-by":"publisher","first-page":"8132","DOI":"10.3390\/ijerph18158132","volume":"18","author":"A Wong","year":"2021","unstructured":"Wong A, Hung KK, Mabhala M, et al. Filling the gaps in the pharmacy workforce in post-conflict areas: experience from four countries in Sub-saharan Africa. Int J Environ Res Public Health. 2021;18(15):8132.","journal-title":"Int J Environ Res Public Health"},{"key":"756_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12960-016-0158-z","volume":"14","author":"I Bates","year":"2016","unstructured":"Bates I, John C, Bruno A, et al. An analysis of the global pharmacy workforce capacity. Hum Resour Health. 2016;14:1\u20137.","journal-title":"Hum Resour Health"},{"key":"756_CR30","unstructured":"Karaki K, Ahairwe PE. Operationalising pharma manufacturing hubs in Africa: Policy options for the EU: ecdpm; 2022.p."},{"key":"756_CR31","unstructured":"Ogada T. Building a competitive and socially inclusive local Pharmaceutical Manufacturing in West Africa through Enhancing Research, Innovation and Intellectual Property. African Center for Technology Studies; 2019."},{"key":"756_CR32","unstructured":"ESS. key findings on the. 2022 Urban Bi-annual employment-unemployment survey: A comparative analysis of february 2022 and June 2022 with annual average. Addis Ababa: Ethiopian Statistics Service (ESS), Government of Ethiopia; 2022."},{"key":"756_CR33","volume-title":"The global gender gap report 2017: insight report","author":"K Schwab","year":"2017","unstructured":"Schwab K, Samans R, Zahidi S, et al. The global gender gap report 2017: insight report. Geneva: World Economic Forum; 2017."},{"key":"756_CR34","doi-asserted-by":"crossref","unstructured":"Christiansen L, Lin H, Pereira J, et al. Gender diversity in senior positions and firm performance: evidence from Europe. International Monetary Fund (IMF); 2016.","DOI":"10.5089\/9781513553283.001"},{"issue":"2","key":"756_CR35","first-page":"131","volume":"9","author":"EO Obukohwo","year":"2018","unstructured":"Obukohwo EO, Olele EH, Buzugbe PN. Assessing efficiency in the pharmaceutical sector of Nigeria. CBN J Appl Stat. 2018;9(2):131\u201348.","journal-title":"CBN J Appl Stat"},{"issue":"5","key":"756_CR36","first-page":"20","volume":"7","author":"P Adeyemi","year":"2016","unstructured":"Adeyemi P, Olufemi O. The determinants of capacity utilization in the Nigerian manufacturing sector. J Econ Sustainable Dev. 2016;7(5):20\u201331.","journal-title":"J Econ Sustainable Dev"},{"key":"756_CR37","volume-title":"The role of Industry Parks in the local economy: the case of small and Medium Enterprises (SMEs) in Ethiopia","author":"UNDP","year":"2024","unstructured":"UNDP. The role of Industry Parks in the local economy: the case of small and Medium Enterprises (SMEs) in Ethiopia. Addis Ababa: United Nations Development Programme (UNDP); 2024."},{"key":"756_CR38","doi-asserted-by":"crossref","unstructured":"Chen X, Xue S, Lv M et al. Pharmaceutical industry in China: Policy, market and IP. Innovation, Economic Development, and Intellectual Property in India and China: Comparing Six Economic Sectors. 2019:215\u2013250.","DOI":"10.1007\/978-981-13-8102-7_10"},{"key":"756_CR39","unstructured":"Sampath PG. Pharmaceutical manufacturing in Bangladesh\u2013a success story: what can we learn. FEAPM Advocacy Ser. 2019(1)."},{"key":"756_CR40","doi-asserted-by":"crossref","unstructured":"Sindkhedkar M, Jagtap S, Shah C, et al. In:. Pharmaceutical research in India: current status and opportunities. Proc Indian Natl Sci Acad; 2020.","DOI":"10.16943\/ptinsa\/2019\/49737"},{"issue":"S1","key":"756_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1017\/jme.2023.118","volume":"51","author":"J Paranhos","year":"2023","unstructured":"Paranhos J, Hasenclever L, Perin FS. The Brazilian Pharmaceutical Industry: actors, institutions, and policies. J Law Med Ethics. 2023;51(S1):126\u201335.","journal-title":"J Law Med Ethics"},{"key":"756_CR42","unstructured":"Tabikh M. Downtime cost and reduction analysis: Survey results. M\u00e4lardalen University; 2014."},{"key":"756_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jlp.2017.09.001","volume":"50","author":"P Goel","year":"2017","unstructured":"Goel P, Aniruddha D, Mannan MS. Industrial alarm systems: challenges and opportunities. J Loss Prev Process Ind. 2017;50:23\u201336.","journal-title":"J Loss Prev Process Ind"},{"key":"756_CR44","unstructured":"Ronoh W. Market Research to identify and analyze supply and demand gaps. COVID-19 Related Pharmaceutical Goods and Services in the COMESA Region: final validated report. Lusaka, Zambia. Common Market for Eastern and Southern Africa (COMESA); 2022."},{"key":"756_CR45","volume-title":"EAC Regional Pharmaceutical Manufacturing Plan of Action 2017\u20132027","author":"EAC","year":"2018","unstructured":"EAC. EAC Regional Pharmaceutical Manufacturing Plan of Action 2017\u20132027. Arusha, Tanzania: East-African Community (EAC); 2018. 2."},{"key":"756_CR46","unstructured":"UNCTAD. Improving the investment landscape for local production of essential antibiotics in Uganda: An Advisory Report. Geneva: United Nations Conference on Trade and Developmen (UNCTAD). 2023. Contract No.: UNCTAD\/TCS\/DIAE\/INF\/2023\/7."},{"key":"756_CR47","unstructured":"Steele P, Ali GKM, Levitskiy A et al. A case for Local Pharmaceutical Manufacturing in Africa in Light of the COVID-19 pandemic. Pamale Steele Associates 2020(1.1):1\u201314."},{"key":"756_CR48","unstructured":"EFPIA. The Pharmaceutical Industry in Figures: Key Data for 2023. Brussels: European Federation of Pharmaceutical Industries and Associations (EFPIA); 2023 [Available from: https:\/\/efpia.eu\/media\/rm4kzdlx\/the-pharmaceutical-industry-in-figures-2023.pdf"},{"key":"756_CR49","doi-asserted-by":"publisher","first-page":"708832","DOI":"10.3389\/fpubh.2021.708832","volume":"9","author":"S Chih-Yi","year":"2021","unstructured":"Chih-Yi S, Yao-Ning G, Kuang-Cheng C, et al. R&D Investments, Debt Capital, and Ownership Concentration: A Three-Way Interaction and lag effects on Firm Performance in China\u2019s Pharmaceutical Industry. Front Public Health. 2021;9:708832.","journal-title":"Front Public Health"},{"issue":"2","key":"756_CR50","doi-asserted-by":"publisher","first-page":"e001047","DOI":"10.1136\/bmjgh-2018-001047","volume":"4","author":"V Simpkin","year":"2019","unstructured":"Simpkin V, Namubiru-Mwaura E, Clarke L, et al. Investing in health R&D: where we are, what limits us, and how to make progress in Africa. BMJ Global Health. 2019;4(2):e001047.","journal-title":"BMJ Global Health"},{"key":"756_CR51","unstructured":"Panteli D, Edwards S. Ensuring access to medicines: how to stimulate innovation to meet patients\u2019 needs? Copenhagen European Observatory on Health Systems and Policies; 2018 [Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526401\/"},{"key":"756_CR52","doi-asserted-by":"publisher","first-page":"902025","DOI":"10.3389\/fpubh.2022.902025","volume":"10","author":"Y Wei","year":"2022","unstructured":"Wei Y, Zhu J, Qiao J, et al. The impact of the consistency evaluation policy of generic drugs on R&D Investment Intensity of Pharmaceutical Companies\u2014An empirical study based on the difference-in-differences model. Front Public Health. 2022;10:902025.","journal-title":"Front Public Health"},{"key":"756_CR53","unstructured":"UNIS. Science, technology and innovation.: UNESCO Institute for Statistics (UNIS). 2024 [Available from: http:\/\/data.uis.unesco.org\/index.aspx?queryid=3685"},{"key":"756_CR54","unstructured":"WHO. Health researchers (in full-time equivalent) per million inhabitants, by income group, World Health Organization (WHO).: 2023 [Available from: https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/indicators\/health-researchers-in-full-time-equivalent-per-million-inhabitants-by-income-group-second-set-of-charts"},{"issue":"6","key":"756_CR55","doi-asserted-by":"publisher","first-page":"e17488","DOI":"10.1016\/j.heliyon.2023.e17488","volume":"9","author":"TC Ezike","year":"2023","unstructured":"Ezike TC, Okpala US, Onoja UL, et al. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023;9(6):e17488.","journal-title":"Heliyon"},{"issue":"S\u20135","key":"756_CR56","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.17762\/jaz.v44iS-5.1719","volume":"44","author":"K Manipriyanka","year":"2023","unstructured":"Manipriyanka K, Naidu RK. Advances in drug Formulation Technology: enhancing bioavailability and patient compliance. J Adv Zool. 2023;44(S\u20135):2125\u201330.","journal-title":"J Adv Zool"},{"key":"756_CR57","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","volume":"21","author":"CJ Bashor","year":"2022","unstructured":"Bashor CJ, Hilton IB, Bandukwala H, et al. Engineering the next generation of cell-based therapeutics. Nat Rev Drug Discov. 2022;21:655\u201375.","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"756_CR58","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.drudis.2018.09.002","volume":"23","author":"M Danhof","year":"2018","unstructured":"Danhof M, K K. The future of drug development: the paradigm shift towards systems therapeutics. Drug Discovery Today. 2018;23(12):1990\u20135.","journal-title":"Drug Discovery Today"},{"issue":"2","key":"756_CR59","first-page":"4","volume":"9","author":"MA Ishaque","year":"2024","unstructured":"Ishaque MA, Gul F, Baloch NA, et al. The impact of job satisfaction on employee performance in Pharmaceutical Industry of Pakistan. NUML J Manage Technol. 2024;9(2):4\u201314.","journal-title":"NUML J Manage Technol"},{"issue":"2","key":"756_CR60","first-page":"47","volume":"7","author":"D Moti","year":"2022","unstructured":"Moti D. Analysis of factors affecting employees\u2019 job satisfaction in selected bureaus of Oromia Regional State, Ethiopia. Afr J Leadersh Dev. 2022;7(2):47\u201363.","journal-title":"Afr J Leadersh Dev"},{"issue":"9","key":"756_CR61","first-page":"113","volume":"1","author":"M Kabir","year":"2011","unstructured":"Kabir M, Parvin MM. Factors affecting employee job satisfaction of pharmaceutical sector. Australian J Bus Manage Res. 2011;1(9):113\u201323.","journal-title":"Australian J Bus Manage Res"},{"issue":"6","key":"756_CR62","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/soc12060167","volume":"12","author":"E Triantafillidou","year":"2022","unstructured":"Triantafillidou E, Koutroukis T. Human resource management, employee participation and European Works councils: the case of pharmaceutical industry in Greece. Societies. 2022;12(6):167.","journal-title":"Societies"},{"key":"756_CR63","unstructured":"Guyo W, Gakure R, Mwangi B, editors. factors contributing to the employee turnover in pharmaceutical companies in Kenya: a case study of Ranbaxy Laboratories limited. Proceedings of 2011 Kabarak Univeristy 1 St Annual International Research Conference; 2011."},{"issue":"1","key":"756_CR64","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/basr.12346","volume":"129","author":"HA Khan","year":"2024","unstructured":"Khan HA, Hayyat A, Ziaullah M, et al. Brain drain in Pakistan\u2019s pharmaceutical industry: factors and solutions. Bus Soc Rev. 2024;129(1):130\u201350.","journal-title":"Bus Soc Rev"},{"key":"756_CR65","unstructured":"Mwangangi FW. Factors affecting employees turnover in the Pharmaceutical industry: a case of Phillips Group of Companies Kenya. The Management University of Africa; 2014."},{"issue":"4","key":"756_CR66","first-page":"58","volume":"18","author":"HJ Hejase","year":"2016","unstructured":"Hejase HJ, El Dirani A, Hamdar B, et al. Employee retention in the pharmaceutical companies: case of Lebanon. J Bus Manage. 2016;18(4):58\u201375.","journal-title":"J Bus Manage"},{"issue":"5","key":"756_CR67","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/admsci13050121","volume":"13","author":"M Gelencs\u00e9r","year":"2023","unstructured":"Gelencs\u00e9r M, Szab\u00f3-Szentgr\u00f3ti G, K\u0151m\u00fcves ZS, et al. The holistic model of Labour Retention: the impact of Workplace Wellbeing factors on Employee Retention. Administrative Sci. 2023;13(5):121.","journal-title":"Administrative Sci"},{"key":"756_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40545-020-00234-2","volume":"13","author":"P Brhlikova","year":"2020","unstructured":"Brhlikova P, Maigetter K, Murison J, et al. Registration and local production of essential medicines in Uganda. J Pharm Policy Pract. 2020;13:1\u20138.","journal-title":"J Pharm Policy Pract"},{"key":"756_CR69","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.techsoc.2015.07.002","volume":"43","author":"HES Harmon","year":"2015","unstructured":"Harmon HES, Dinar K. Regulating in developing countries: multiple roles for medical research and products regulation in Argentina and India. Technol Soc. 2015;43:10\u201322.","journal-title":"Technol Soc"},{"key":"756_CR70","doi-asserted-by":"crossref","unstructured":"Pezzola A, Sweet MC. Global pharmaceutical regulation: the challenge of integration for developing states. Global Health. 2016;12(85).","DOI":"10.1186\/s12992-016-0208-2"},{"issue":"21","key":"756_CR71","doi-asserted-by":"publisher","first-page":"579","DOI":"10.5897\/AJPP2014.4029","volume":"8","author":"J Ogaji","year":"2014","unstructured":"Ogaji J, Alawode AO, Iranloye TA. Pharmaceutical industry capacity utilization in Nigeria. Afr J Pharm Pharmacol. 2014;8(21):579\u201385.","journal-title":"Afr J Pharm Pharmacol"},{"issue":"2","key":"756_CR72","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.redee.2015.10.004","volume":"25","author":"DME Barbosa","year":"2016","unstructured":"Barbosa DME, Ayala AH, Sandoval AA. The Colombian pharmaceutical industry: factors affecting export. Eur J Manage Bus Econ. 2016;25(2):39\u201346.","journal-title":"Eur J Manage Bus Econ"},{"issue":"1","key":"756_CR73","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40545-022-00491-3","volume":"15","author":"MN Selam","year":"2022","unstructured":"Selam MN, Abera S, Geremew H, et al. Local pharmaceutical research and development capacity in a developing country: a qualitative exploration of perspectives from key stakeholders in Ethiopia. J Pharm Policy Pract. 2022;15(1):92.","journal-title":"J Pharm Policy Pract"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-025-00756-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-025-00756-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-025-00756-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:59:27Z","timestamp":1741085967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-025-00756-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1007\/s43441-025-00756-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4912327\/v1","asserted-by":"object"}]},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was obtained from the Institutional Review Board of the authors\u2019 institute (CHS_IRB-086\/19\/SoP:02\/2021). Verbal consent was obtained from all study participants prior to data collection, responses were anonymized and confidentiality was strictly maintained during data analysis and reporting of the findings.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}